Human Phenotype Project
AI-powered precision from molecular signatures
Israel
Human Phenotype Project is a 25-year longitudinal research initiative launched in 2018. It collects deep-phenotype multi-omics datasets and applies AI-driven analytics to identify novel biomarkers, personalize treatments, and accelerate drug development.
Source: HealthTechAlpha
HealthTechAlpha provided this information. To learn more and get deep data on all digital health companies, please visit them here.
Visit HealthTechAlpha →How We Help
Problem Statement
The lack of comprehensive, longitudinal multi-omics data hinders the identification of novel biomarkers, personalization of treatments, and acceleration of drug development.
Core Technology
AI-driven analytics
Key Differentiators
deep-phenotype multi-omics datasets across genomics, proteomics, metabolomics, imaging, and clinical data; 25-year longitudinal research initiative; Proprietary datasets include 28,000+ enrolled participants with 13,000+ completing initial visits
Clinical Focus
novel biomarkers; personalized treatments; drug development
Company Info
- Business Model
- Platform
- Founded
- 2018
- Website
- humanphenotypeproject.org/
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
Nature Medicine published 2025; AI outperforms standard care in disease prediction; GluFormer and COMPRER models validated on cardiovascular and metabolic disease; funded by Minerva foundation, ERC, and Israel Science Foundation
MedStartr Index Score
?What do you think of Human Phenotype Project?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.